Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMJVFK7)

Drug Name
Meplazumab Drug Info
Synonyms Mepolizumab
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 1/2 [1]
Therapeutic Class
Antiviral Agents
Cross-matching ID
TTD Drug ID
DMJVFK7

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
HUMAN basigin (BSG) TTG21IS BASI_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT04275245) Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia. U.S. National Institutes of Health.
2 Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial